Transferrin receptor overexpression enhances transferrin responsiveness and the metastatic growth of a rat mammary adenocarcinoma cell line Philip G. CavanaughLi Bin JiaGarth L. Nicolson OriginalPaper Pages: 201 - 215
Comparison of immunocytochemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequence–based amplification for the detection of circulating breast cancer cells A.C. LambrechtsA.J. BosmaS. Rodenhuis OriginalPaper Pages: 217 - 229
Weekly epirubicin plus lonidamine in advanced breast carcinoma Cecilia NisticòCarlo GarufiEdmondo Terzoli OriginalPaper Pages: 231 - 235
Cisplatin–epirubicin–paclitaxel weekly administration in advanced breast cancer: A phase I study of the Southern Italy Cooperative Oncology Group Giuseppe FrasciGiuseppe D'AiutoGiuseppe Comella OriginalPaper Pages: 237 - 250
pS2 (TFF1) levels in human breast cancer tumor samples: correlation with clinical and histological prognostic markers Bradley E. GillesbyTimothy R. Zacharewski OriginalPaper Pages: 251 - 263
Effective treatment of advanced estrogen–independent MXT mouse mammary cancers with targeted cytotoxic LH–RH analogs Karoly SzepeshaziAndrew V. SchallyAttila Nagy OriginalPaper Pages: 265 - 274
Retinoic acid receptor antagonist BMS453 inhibits the growth of normal and malignant breast cells without activating RAR–dependent gene expression L. YangD. Munoz–MedellinP.H. Brown OriginalPaper Pages: 275 - 289